中西医结合诊疗在骨质疏松症中的研究进展
Research Progress in the Diagnosis and Treatment of Osteoporosis through Integrative Traditional Chinese and Western Medicine
摘要: 骨质疏松症(osteoporosis)是一种以骨骼质量减少和骨组织微结构恶化为特征的慢性骨代谢性疾病,主要影响老年人,特别是女性。该病导致骨骼易于骨折,从而增加了患者的残疾和死亡风险。近年来,中西医结合诊疗骨质疏松症的研究逐渐受到关注,并取得了显著进展。这种综合治疗方法有望成为未来治疗骨质疏松症的重要手段,为患者提供更多治疗选择,改善其生活质量。然而,仍需要更多的研究来进一步验证中西医结合治疗的长期效果和安全性,以更好地指导临床实践。本论文旨在综述中西医结合在骨质疏松症治疗领域的最新研究进展。
Abstract: Osteoporosis is a chronic metabolic bone disorder characterized by reduced bone mass and deteri-oration of bone microarchitecture, primarily affecting the elderly population, especially women. This condition leads to an increased risk of fractures, contributing to higher rates of disability and mortality among affected individuals. In recent years, research on the integration of traditional Chinese medicine and Western medicine in the diagnosis and treatment of osteoporosis has gained considerable attention and has made significant progress. This integrated approach holds promise as an essential strategy for future osteoporosis management, offering patients a broader range of treatment options and potentially enhancing their quality of life. However, further research is needed to validate the long-term effectiveness and safety of the combined Chinese and Western medicine treatment, providing better guidance for clinical practice. This paper aims to review the latest advancements in the field of integrated Chinese and Western medicine treatment for osteo-porosis.
文章引用:戴高远, 陈海啸. 中西医结合诊疗在骨质疏松症中的研究进展[J]. 临床医学进展, 2023, 13(10): 16118-16122. https://doi.org/10.12677/ACM.2023.13102252

参考文献

[1] Barnsley, J., Buckland, G., Chan, P.E., et al. (2021) Pathophysiology and Treatment of Osteoporosis: Challenges for Clinical Practice in Older People. Aging Clinical and Experimental Research, 33, 759-773. [Google Scholar] [CrossRef] [PubMed]
[2] Zhang, N., Han, T., Huang, B.K., et al. (2016) Traditional Chi-nese Medicine Formulas for the Treatment of Osteoporosis: Implication for Antiosteoporotic Drug Discovery. Journal of Ethnopharmacology, 189, 61-80. [Google Scholar] [CrossRef] [PubMed]
[3] Kimball, J., Johnson, J. and Carlson, D. (2021) Oxidative Stress and Osteoporosis. The Journal of Bone and Joint Surgery. American Volume, 103, 1451-1461. [Google Scholar] [CrossRef
[4] 靳子星, 骆菲. 中西医治疗绝经后骨质疏松症的研究进展[J]. 婚育与健康, 2023, 29(10): 76-78.
[5] 邓若尘, 房庆城, 方睿. 绝经后骨质疏松症与氧化应激的相关性研究[J]. 现代医院, 2022, 22(2): 310-312+315.
[6] 赵东峰, 唐德志. 骨质疏松症中西医结合诊疗专家共识[J]. 世界中医药, 2023, 18(7): 887-894.
[7] Clynes, M., Harvey, N.C., Curtis, E.M., et al. (2020) The Epidemiology of Osteoporosis. British Medical Bulletin, 133, 105-117. [Google Scholar] [CrossRef] [PubMed]
[8] Schuiling, K., Robinia, K. and Nye, R. (2011) Osteoporosis Update. Journal of Midwifery & Women’s Health, 56, 615-627. [Google Scholar] [CrossRef] [PubMed]
[9] Lane, N. (2006) Epidemiology, Etiology, and Diagnosis of Osteoporosis. American Journal of Obstetrics and Gynecology, 194, S3-S11. [Google Scholar] [CrossRef] [PubMed]
[10] 中华医学会骨质疏松和骨矿盐疾病分会, 章振林. 原发性骨质疏松症诊疗指南(2022) [J]. 中国全科医学, 2023, 26(14): 1671-1691.
[11] 董万涛, 吕泽斌, 宋敏, 柴居堂. 中医“骨枯髓空”的病理机制及从肾论治原发性骨质疏松症的科学涵义[J]. 中国骨质疏松杂志, 2014, 20(10): 1245-1249.
[12] Li, Q., Tian, C.Q., Liu, X.J., et al. (2023) Anti-Inflammatory and Antioxidant Traditional Chinese Medicine in Treatment and Prevention of Osteoporosis. Frontiers in Pharmacology, 14, Article ID: 1203767. [Google Scholar] [CrossRef] [PubMed]
[13] 沈智蓉, 耿春梅, 杨爽. 双能X线骨密度仪椎体骨密度测定对骨质疏松症的诊断价值[J]. 影像研究与医学应用, 2019, 3(22): 173-174.
[14] Zhao, X., Patil, S., Xu, F., et al. (2021) Role of Biomolecules in Osteoclasts and Their Therapeutic Potential for Osteoporosis. Biomolecules, 11, Article No. 747. [Google Scholar] [CrossRef] [PubMed]
[15] Gyanewali, S., Kesharwani, P., Sheikh, A., et al. (2021) Formulation Development and in Vitro-in Vivo Assessment of Protransfersomal Gel of Anti-Resorptive Drug in Osteo-porosis Treatment. International Journal of Pharmaceutics, 608, Article ID: 121060. [Google Scholar] [CrossRef] [PubMed]
[16] Rossouw, J., Anderson, G.L., Prentice, R.L., et al. (2002) Risks and Benefits of Estrogen plus Progestin in Healthy Postmenopausal Women: Principal Results from the Women’s Health Initiative Randomized Controlled Trial. JAMA, 288, 321-333. [Google Scholar] [CrossRef] [PubMed]
[17] Lu, J.J., et al. (2022) Advances in Our Understanding of the Mecha-nism of Action of Drugs (Including Traditional Chinese Medicines) for the Intervention and Treatment of Osteoporosis. Frontiers in Pharmacology, 13, Article ID: 938447. [Google Scholar] [CrossRef] [PubMed]
[18] 彭斯伟, 宋敏, 范凯, 等. 单味中药治疗肾虚型骨质疏松症机制研究状况[J]. 中国临床药理学杂志, 2022, 38(1): 76-80.
[19] 薛纯纯, 刘爽, 陈林, 等. 从肾脏调控骨的物质基础阐释“肾主骨”的科学内涵[J]. 中华中医药杂志, 2022, 37(3): 1574-1578.
[20] 陈鲁峰, 王庆敏, 高建平, 等. 中药治疗老年骨质疏松性椎体压缩性骨折临床观察[J]. 光明中医, 2019, 34(1): 53-55.
[21] Ma, H., He, X., Yang, Y., et al. (2011) The Genus Epimedium: an Ethnopharmacological and Phytochemical Review. Journal of Ethnopharmacology, 134, 519-541. [Google Scholar] [CrossRef] [PubMed]
[22] Indran, I., Liang, R.L., Min, T.E., et al. (2016) Preclinical Studies and Clinical Evaluation of Compounds from the Genus Epimedium for Osteoporosis and Bone Health. Pharmacology & Therapeutics, 162, 188-205. [Google Scholar] [CrossRef] [PubMed]
[23] Zhao, J., Xu, J., Xu, Y., et al. (2020) Epimedi-umHigh-Throughput Metabolomics Method for Discovering Metabolic Biomarkers and Pathways to Reveal Effects and Molecular Mechanism of Ethanol Extract from against Osteoporosis. Frontiers in Pharmacology, 11, Article No. 1318. [Google Scholar] [CrossRef] [PubMed]
[24] 谢亮. 补肾活血汤治疗老年骨质疏松性椎体压缩骨折PKP术后的临床疗效观察[D]: [硕士学位论文]. 南昌: 江西中医药大学, 2020.
[25] 蔡瑞玉. 中西医结合治疗原发性骨质疏松症临床观察[J]. 河北中医, 2016, 38(5): 713-717.
[26] Shi, S., Wang, F., Yao, H., et al. (2021) Oral Chinese Herbal Medicine on Immune Responses during Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Frontiers in Medicine, 8, Article ID: 685734. [Google Scholar] [CrossRef] [PubMed]